Loading viewer...
conference
Format: PDF conference
GlaxoSmithKline presented at the J.P. Morgan Healthcare Conference in January 2024, highlighting double-digit sales and adjusted operating profit growth in Q3 and 9 months 2023. The presentation focused on momentum in Vaccines and Specialty Medicines, including the launch of Arexvy, the first-ever RSV vaccine, and £7.8 billion in sales from products launched since 2017.
brochure
conference
22 Pages
Uniti Group
Lightning eMotors Needham Growth Conference 2023
conferenceconference
29 Pages
Lightning eMotors, Inc.